Cryptococcus gattii in the United States: Genotypic Diversity of Human and Veterinary Isolates

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Lockhart, Shawn R ^a   Iqbal, Naureen ^a   Harris, Julie R ^a   Grossman, Nina T ^a   DeBess, Emilio ^b   Wohrle, Ron ^c   Marsden Haug, Nicola ^c   Vugia, Duc J ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b OREGON DEPARTMENT OF HUMAN SERVICES   (United States)

^c WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CRYPTOCOCCUS GATTII; FUNGAL STRAIN; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; MATING TYPE; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; UNITED STATES;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; GENOTYPE; HUMANS; NORTHWESTERN UNITED STATES; PHYLOGENY; UNITED STATES;

EID: 84883424332     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074737     Document Type: Article

References (68)

1. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, et al. (1995) Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 20: 611-616. doi:10.1093/clinids/20.3.611. PubMed: 7756484.
2. Speed B, Dunt D, (1995) Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 21: 28-34. doi:10.1093/clinids/21.1.28. PubMed: 7578756.
3. Friedman GD, Fessel WJ, Udaltsova NV, Hurley LB, (1995) Cryptococcosis: the 1981-2000 epidemic. Mycoses 48: 122-125.
4. Harris JR, Lockhart SR, DeBess EE, Marsden-Haug N, Goldoft M, et al. (2011) Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis 53: 1188-1195. doi:10.1093/cid/cir723. PubMed: 22016503.
5. Galanis E, Hoang L, Kibsey P, Morshed M, Phillips P, (2009) Clinical presentations, diagnosis and management of Cryptococcus gattii cases: lessons learned from British Columbia. Can J Infect Dis Med Microbiol 20: 23-28. PubMed: 20190892.
6. Steele KT, Thakur R, Nthobatsang R, Steenhoff AP, Bisson GP, (2010). In-hospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii and C. neoformans infection in Gaborone, Botswana. Med Mycol 48: 1112-1115.
7. Chaturvedi S, Dyavaiah M, Larsen RA, Chaturvedi V, (2005) Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis 11: 1686-1692. doi:10.3201/eid1111.040875. PubMed: 16318719.
8. Kwon-Chung KJ, Bennett JE, (1984) Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 120: 123-130. PubMed: 6377880.
9. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, et al. (2004) A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A 101: 17258-17263. doi:10.1073/pnas.0402981101. PubMed: 15572442.
10. Okamoto K, Hatakeyama S, Itoyama S, Nukui Y, Yoshino Y, et al. (2010) Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg Infect Dis 16: 1155-1157. doi:10.3201/eid1607.100106. PubMed: 20587194.
11. Chowdhary A, Randhawa HS, Boekhout T, Hagen F, Klaassen CH, et al. (2012) Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg Infect Dis 18: 172-174. doi:10.3201/eid1801.111190. PubMed: 22261398.
12. Hagen F, Colom MF, Swinne D, Tintelnot K, Iatta R, et al. (2012) Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis 18: 1618-1624. doi:10.3201/eid1810.120068. PubMed: 23017442.
13. Bovers M, Hagen F, Kuramae EE, Boekhout T, (2008) Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing. Fungal Genet Biol 45: 400-421. doi:10.1016/j.fgb.2007.12.004. PubMed: 18261945.
14. Ngamskulrungroj P, Gilgado F, Faganello J, Litvintseva AP, Leal AL, et al. (2009) Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLOS ONE 4: e5862. doi:10.1371/journal.pone.0005862. PubMed: 19517012.
15. Meyer W, Castañeda A, Jackson S, Huynh M, Castañeda E, et al. (2003) Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 9: 189-195. doi:10.3201/eid0902.020246. PubMed: 12603989.
16. Campbell LT, Fraser JA, Nichols CB, Dietrich FS, Carter D, et al. (2005) Clinical and environmental isolates of Cryptococcus gattii from Australia that retain sexual fecundity. Eukaryot Cell 4: 1410-1419. doi:10.1128/EC.4.8.1410-1419.2005. PubMed: 16087746.
17. Litvintseva AP, Thakur R, Reller LB, Mitchell TG, (2005) Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J Infect Dis 192: 888-892. doi:10.1086/432486. PubMed: 16088839.
18. Feng X, Yao Z, Ren D, Liao W, Wu J, (2008) Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients. FEMS Yeast Res 8: 930-938. doi:10.1111/j.1567-1364.2008.00422.x. PubMed: 18671745.
19. Trilles L, Lazéra, Mdos S, Wanke B, Oliveira RV, Barbosa et al (2008) Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. Mem Inst Oswaldo Cruz 103: 455-462 PubMed: 18797758.
20. Hagen F, Illnait-Zaragozi MT, Bartlett KH, Swinne D, Geertsen E, et al. (2010) In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother 54: 5139-5145. doi:10.1128/AAC.00746-10. PubMed: 20855729.
21. Chowdhary A, Randhawa HS, Sundar G, Kathuria S, Prakash A, et al. (2011) In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India. J Med Microbiol 60: 961-967. doi:10.1099/jmm.0.029025-0. PubMed: 21393452.
22. Bennett JE, Kwon-Chung KJ, Howard DH, (1977) Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 105: 582-586. PubMed: 326036.
23. Kwon-Chung KJ, Bennett JE, (1984) High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl Bakteriol Mikrobiol Hyg A 257: 213-218. PubMed: 6207684.
24. Kwon-Chung KJ, Bennett JE, (1984) Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 120: 123-130. PubMed: 6377880.
25. Pfeiffer T, Ellis D, (1991) Environmental isolation of Cryptococcus neoformans gattii from California. J Infect Dis 163: 929-930. doi:10.1093/infdis/163.4.929. PubMed: 2010649.
26. Brandt ME, Hutwagner LC, Klug LA, Baughman WS, Rimland D, et al. (1996) Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. J Clin Microbiol 34: 912-917. PubMed: 8815107.
27. Stephen C, Lester S, Black W, Fyfe M, Raverty S, (2002) Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia, Can. Vet J 43: 792-794.
28. Fraser JA, Subaran RL, Nichols CB, Heitman J, (2003) Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada. Eukaryot Cell 2: 1036-1045. doi:10.1128/EC.2.5.1036-1045.2003. PubMed: 14555486.
29. Hoang LM, Maguire JA, Doyle P, Fyfe M, Roscoe DL, (2004) Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology. J Med Microbiol 53: 935-940. doi:10.1099/jmm.0.05427-0. PubMed: 15314203.
30. Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, et al. (2005) Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437: 1360-1364. doi:10.1038/nature04220. PubMed: 16222245.
31. Upton A, Fraser JA, Kidd SE, Bretz C, Bartlett KH, (2007) First contemporary case of human infection with Cryptococcus gattii in Puget Sound: evidence for spread of the Vancouver Island outbreak. J Clin Microbiol 45: 3086-3088. doi:10.1128/JCM.00593-07. PubMed: 17596366.
32. Kidd SE, Chow Y, Mak S, Bach PJ, Chen H, et al. (2007) Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Appl Environ Microbiol 73: 1433-1443. doi:10.1128/AEM.01330-06. PubMed: 17194837.
33. MacDougall L, Kidd SE, Galanis E, Mak S, Leslie MJ, et al. (2007) Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis 13: 42-50. doi:10.3201/eid1301.060827. PubMed: 17370514.
34. Datta K, Bartlett KH, Baer R, Byrnes E, Galanis E, et al. (2009) Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis 15: 1185-1191. doi:10.3201/eid1508.081384. PubMed: 19757550.
35. Byrnes EJ 3rd, Bildfell RJ, Frank SA, Mitchell TG, Marr KA, et al. (2009) Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis 199: 1081-1086. doi:10.1086/597306. PubMed: 19220140.
36. Byrnes EJ 3rd, Li W, Lewit Y, Ma H, Voelz K, et al. (2010) Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLOS Pathog 6: e1000850. PubMed: 20421942.
37. Iqbal N, DeBess EE, Wohrle R, Sun B, Nett RJ, et al. (2010) Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol 48: 539-544. doi:10.1128/JCM.01505-09. PubMed: 20007380.
38. Denton JF, Di Salvo AF, (1968) The prevalence of Cryptococcus neoformans in various natural habitats. Sabouraudia 6: 213-217. doi:10.1080/00362176885190411. PubMed: 5679667.
39. Wilson DE, Bennett JE, Bailey JW, (1968) Serologic grouping of Cryptococcus neoformans. Proc Soc Exp Biol Med 127: 820-823. doi:10.3181/00379727-127-32812. PubMed: 5651140.
40. Kwon-Chung KJ, (1976) A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia 68: 942-946. doi:10.2307/3758813. PubMed: 790173.
41. Fromtling RA, Shadomy S, Shadomy HJ, Dismukes WE, (1982) Serotype B/C Cryptococcus neoformans isolated from patients in nonendemic areas. J Clin Microbiol 16: 408-410. PubMed: 6749900.
42. Bottone EJ, Kirschner PA, Salkin IF, (1986) Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City. J Clin Microbiol 23: 186-188. PubMed: 3517042.
43. Byrnes EJ 3rd, Li W, Lewit Y, Perfect JR, Carter DA, (2009) First reported case of Cryptococcus gattii in the Southeastern USA: implications for travel-associated acquisition of an emerging pathogen. PLOS ONE 4: e5851. doi:10.1371/journal.pone.0005851. PubMed: 19516904.
44. McCulloh RJ, Phillips R, Perfect JR, Byrnes EJ 3rd, Heitman J, et al. (2011) Cryptococcus gattii genotype VGI Infection in New England. Pediatr Infect Dis J 30: 1111-1114. doi:10.1097/INF.0b013e31822d14fd. PubMed: 21814154.
45. Walraven CJ, Gerstein W, Hardison SE, Wormley F, Lockhart SR, et al. (2011) Fatal disseminated Cryptococcus gattii infection in New Mexico. PLOS ONE 6: e28625. doi:10.1371/journal.pone.0028625. PubMed: 22194869.
46. Byrnes EJ 3rd, Li W, Ren P, Lewit Y, Voelz K, (2011) A diverse population of Cryptococcus gattii molecular type VGIII in Southern California HIV/AIDS patients. PLOS Pathog 7: e1002205.
47. Sellers B, Hall P, Cine-Gowdie S, Hays AL, Patel K, (2012) Cryptococcus gattii. An Emerging Fungal Pathog Southeastern United States. AM J Med Sci 343: 510-511.
48. Kunadharaju R, Choe U, Harris JR, Lockhart SR, Greene JN, (2013) Cryptococcus gattii: Emerging fungal pathogen in Florida. Emerg Infect Dis, 19: 519-521. PubMed: 23750364.
49. Kwon-Chung KJ, Polacheck I, Bennett JE, (1982) Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 15: 535-537. PubMed: 7042750.
50. Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, et al. (2009) Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 12: 1-14. PubMed: 19462334.
51. Hall TA, (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp 41: 95-98.
52. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis(MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
53. Ngamskulrungroj P, Sorrell TC, Chindamporn A, Chaiprasert A, Poonwan N, et al. (2008) Association between fertility and molecular sub-type of global isolates of Cryptococcus gattii molecular type VGII. Med Mycol 46: 665-673. doi:10.1080/13693780802210734. PubMed: 18651305.
54. Campbell LT, Fraser JA, Nichols CB, Dietrich FS, Carter D, et al. (2005) Clinical and environmental isolates of Cryptococcus gattii from Australia that retain sexual fecundity. Eukaryot Cell 4: 1410-1419. doi:10.1128/EC.4.8.1410-1419.2005. PubMed: 16087746.
55. Evans EE, (1949) An immunologic comparison of twelve strains of Cryptococcus neoformans (Torula histolytica). Proc Soc Exp Biol Med 71: 644-646. doi:10.3181/00379727-71-17283. PubMed: 18148185.
56. Kwon-Chung KJ, (1976) A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia 68: 943-946. PubMed: 790173.
57. Kwon-Chung KJ, Bennett JE, Theodore TS, (1978) Cryptococcus bacillisporus sp. nov. Serotype B-C of Cryptococcus neoformans. Int J Syst Bacteriol 28: 616-620. doi:10.1099/00207713-28-4-616.
58. Diaz MR, Boekhout T, Theelen B, Fell JW, (2000) Molecular sequence analyses of the intergenic spacer (IGS) associated with rDNA of the two varieties of the pathogenic yeast, Cryptococcus neoformans. Syst Appl Microbiol 23: 535-545. doi:10.1016/S0723-2020(00)80028-4. PubMed: 11249024.
59. Muchmore HG, Scott EN, Felton FG, Fromtling RA, (1980) Cryptococcus neoformans serotype groups encountered in Oklahoma. Am J Epidemiol 112: 323-328. PubMed: 7424881.
60. Carriconde F, Gilgado F, Arthur I, Ellis D, Malik R, et al. (2011) Clonality and α-a recombination in the Australian Cryptococcus gattii VGII population--an emerging outbreak in Australia. PLOS ONE. 6: e16936. doi:10.1371/journal.pone.0016936. PubMed: 21383989.
61. Meyer W, Gilgado F, Ngamskulrungroj P, Trilles L, Hagen F, et al. (2011) Molecular typing of Cryptococcus neoformans/Cryptococcus gattii species complex. In: Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A, eds. Cryptococcus from Human Pathogen to Model Yeast. Washington DC: ASM Press. p. pp. 2011. pp.-358.
62. Harris JR, Lockhart SR, Crist M, Aminu L, Sellers B, et al. (2013) Cryptococcus gattii: an endemic infection in multiple states outside the Pacific Northwest US. Emerg Infect Dis (In press).
63. Hagen F, Illnait-Zaragozi MT, Bartlett KH, Swinne D, Geertsen E, et al. (2010) In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother 54: 5139-5145. doi:10.1128/AAC.00746-10. PubMed: 20855729.
64. Lockhart SR, Iqbal N, Bolden CB, DeBess EE, Marsden-Haug N, et al. (2012) Epidemiological cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility. Diagn Microbiol Infect Dis, 73: 144-148. doi:10.1016/j.diagmicrobio.2012.02.018. PubMed: 22494557.
65. Espinel-Ingroff A, Aller AI, Canton E, Castañón-Olivares LR, Chowdhary A, et al. (2012) Cryptococcus neoformans-Cryptococcus gattii Species Complex: An International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole and Voriconazole. Antimicrob Agents Chemother, 56: 5898-5906. doi:10.1128/AAC.01115-12. PubMed: 22948877.
66. López-Martínez R, Soto-Hernández JL, Ostrosky-Zeichner L, Castanón-Olivares LR, Angeles-Morales V, et al. (1996) Cryptococcus neoformans var. gattii among patients with cryptococcal meningitis in Mexico. First observations. Mycopathologia. 134: 61-64. doi:10.1007/BF00436865. PubMed: 8981772.
67. Chen YC, Chang SC, Shih CC, Hung CC, Luhbd KT, et al. (2000) Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. Diagn Microbiol Infect Dis 36: 175-183.
68. Chen SC, Slavin MA, Heath CH, Playford EG, Byth K, et al. (2012) Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis 55: 789-798. doi:10.1093/cid/cis529. PubMed: 22670042.